You May Also Like

User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya
Cite
CITE Title : User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya Personal Author(s) : Hill, Jenny;Hoyt, Jenna;Achieng, Florence;Ouma, Peter;L’lanziva, Anne;Kariuki, Simon;Desai, Meghna;Webster, Jayne; Published Date : Mar 17 2016 Source : PLoS One. 11(3). URL : https://stacks.cdc.gov/view/cdc/38847 Hill, Jenny et al. (2016). User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya. 11(3). Hill, Jenny et al. "User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya" 11, no. 3 (2016) Hill, Jenny et al. "User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya" vol. 11, no. 3, 2016 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 426.51 KB]
Personal Author:
Hill, Jenny ;
Hoyt, Jenna
...
Mar 17 2016 | PLoS One. 11(3).
Description:
BackgroundThe World Health Organization recommends intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) alongsid...
File Type:
[PDF - 426.51 KB]
File Type:
[PDF - 426.51 KB]

Intervillous Macrophage Migration Inhibitory Factor Is Associated with Adverse Birth Outcomes in a Study Population in Central India
Cite
CITE Title : Intervillous Macrophage Migration Inhibitory Factor Is Associated with Adverse Birth Outcomes in a Study Population in Central India Personal Author(s) : Singh, Puspendra P.;Lucchi, Naomi W.;Blackstock, Anna;Udhayakumar, Venkatachalam;Singh, Neeru; Published Date : Dec 13 2012 Source : PLoS One. 2012; 7(12). URL : https://stacks.cdc.gov/view/cdc/12159 Singh, Puspendra P. et al. (2012). Intervillous Macrophage Migration Inhibitory Factor Is Associated with Adverse Birth Outcomes in a Study Population in Central India. 7(12). Singh, Puspendra P. et al. "Intervillous Macrophage Migration Inhibitory Factor Is Associated with Adverse Birth Outcomes in a Study Population in Central India" 7, no. 12 (2012) Singh, Puspendra P. et al. "Intervillous Macrophage Migration Inhibitory Factor Is Associated with Adverse Birth Outcomes in a Study Population in Central India" vol. 7, no. 12, 2012 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 226.41 KB]
Personal Author:
Singh, Puspendra P. ;
Lucchi, Naomi W.
...
Dec 13 2012 | PLoS One. 2012; 7(12).
Description:
Macrophage migration inhibitory factor (MIF) is a pluripotent factor produced by a variety of cells. It plays an important biological role in the regu...
File Type:
[PDF - 226.41 KB]
File Type:
[PDF - 226.41 KB]